Semaglutide Delivers 14–17% Weight Loss in Landmark Review, but Gains Fade After Stopping
A new systematic review of 15 studies confirms semaglutide's clinically meaningful weight-loss benefits while cautioning that results vary by dose, ...
A new systematic review of 15 studies confirms semaglutide's clinically meaningful weight-loss benefits while cautioning that results vary by dose, ...
A pilot randomized trial found that a digital wellness app or medically tailored meals sharply reduced early weight regain after ...
A new JAMA Perspective argues that GLP-1 therapies must be embedded in multimodal obesity care combining screening, early management, and ...
UTHealth Houston researchers have received a five-year, $4 million NIH grant to identify genetic markers and molecular mechanisms behind weight ...
The European Society of Endocrinology has launched the ESE Obesity and Endocrinology School 2027, a three-day Barcelona programme training 25 ...
As powerful new weight-loss drugs transform obesity treatment, leading surgeons argue that metabolic bariatric surgery remains an essential, durable component ...
A Bayesian re-analysis of six clinical trials estimates that people who stop semaglutide or tirzepatide regain roughly one kilogram per ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine